
UMass Cancer Center
@umasscancerctr
Advancing #CancerResearch with hallmark in basic science | Affiliated with @UMassChan
ID: 1168911319740899328
https://www.umassmed.edu/cancer-center/ 03-09-2019 15:39:32
559 Tweet
549 Followers
283 Following

Thrilled to share our recent paper published online Cell Reports led by our graduate student Dimpi Dimpi Mukhopadhyay PhD š³ļøāš š UMass Chan Medical School UMass Cancer Center Molecular, Cell and Cancer Biology Morningside Graduate School of Biomedical Sciences cell.com/cell-reports/fā¦

Congratulations to Shyam Patel, Jonathan Gerber & team on the @ASH_Hematology abstract! They evaluated a test that detects #TP53 mutations in #AML and #MDS more quickly than #nextgen sequencing, guiding earlier management decisions. UMass Chan Medical School journals.lww.com/oncology-timesā¦

Thank you UroToday.com for hosting this talk where we discuss IO related updates in NMIBC. Department of Medicine UMass Cancer Center UMass Chan Medical School Bladder Cancer Advocacy Network

In a new #VoicesofUMassChan #podcast, Marcus Ruscetti, PhD, said he initially tried not take after his scientist parents. Listen to the full podcast about Dr. Ruscetti's prostate cancer research on Jan. 31: direc.to/kSVm Marcus Ruscetti Lab Molecular, Cell and Cancer Biology UMass Cancer Center

Congratulations to the winner of the 2024 Chancellorās Award for Advancing Institutional Excellence in Diversity and Inclusion, announced today. Sharina Person, PhD, was instrumental in the creation of the Diversity Engagement Survey, used at UMass Chan Medical School & institutions nationwide.


Check out the Cancer Center blog featuring the work of Shyam Patel and team! They are exploring the dangers of the #TP53 mutation in #AML and ways to block its action. umassmed.edu/cancer-center/ā¦

Check out the Cancer Center blog featuring the work of Shyam Patel and team! They are exploring the dangers of the #TP53 mutation in #AML and ways to block its action. umassmed.edu/cancer-center/⦠UMass Chan Medical School Department of Medicine

Check out the new blog on the Cancer Center website! @tssannes tells us about how he removes barriers for cancer patients and their caregivers when #psychosocial support is sorely needed. Give it a read! umassmed.edu/cancer-center/⦠UMass Chan Medical School

Thanks to Sharina Person, PhD, for partnering to develop the Diversity Engagement Survey providing a framework to measure and improve our culture and climate. Well-deserved award! bit.ly/3UK8XRf UMass Chan Medical School


Check out the new blog on the UMass Cancer Center website featuring the work of Lucio Castilla, PhD. Learn what he and his collaborators are doing to develop an antibody-nanogel conjugate to treat inversion(16) acute myeloid leukemia. umassmed.edu/cancer-center/ā¦ā¦ UMass Chan Medical School #AML


Congratulations to Dave Guertin and PitarresiPhD for receiving funding from the Department of Defense šŗšø to study the mechanisms of pancreatic ductal adenocarcinoma-associated cachexia. umassmed.edu/medicine/reseaā¦ā¦ #PDAC UMass Chan Medical School Department of Medicine


Drs. Jason Pitarresi, and David Guertin, have received funding from the Department of Defense for their project, āDetermining the Molecular Etiology of and Strategies to Block Pancreatic Cancer Cachexia." Learn more below! PitarresiPhD UMass Chan Medical School umassmed.edu/medicine/reseaā¦



.Shyam Patel, Jonathan Gerber, MD, & team found that DNMT3A, TET2, or ASXL1 mutations in #clonalhematopoiesis pose a lower risk of progressing to myeloid neoplasm than others, with RUNX1 carrying very high risk. pubmed.ncbi.nlm.nih.gov/38522849/ British Journal of Haematology UMass Chan Medical School


Outstanding collaborative effort including UMass Chan Medical School, UMass Cancer Center, Dana-Farber, Boston Children's, Boston U Chobanian & Avedisian School of Medicine & iCureASPS; supported by National Cancer Institute and Sarcoma Foundation of America. Thanks to thoughtful reviewers and editorial staff Cancer Research. #Sarcoma #CureSarcoma

.Matt Hemming uncovered ASPSCR1::TFE3's role in alveolar soft part sarcoma. Their Cancer Research paper highlights promising strategies targeting angiogenesis and cell cycle regulation. Check it out! bit.ly/3QnDFfN @UMasschan Department of Medicine



New research on alveolar soft part sarcoma (ASPS) by Matt Hemming is featured on the Cancer Center website. The team delved into the mechanistic underpinnings of ASPS revealing a targetable vulnerability. Check it out! UMass Chan Medical School Department of Medicine Cancer Research bit.ly/4dymqCD